“`html
Researchers have cultivated miniature brain models using cells from patients, uncovering significant variations in how brain tissue associated with Alzheimer’s disease reacts to an antidepressant. These organoids, along with the particles they emit, hold potential for steering more personalized treatment approaches and could offer fresh insights into diagnosing the disease.
“`
Originally published at www.sciencedaily.com
